ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
176 hedge funds and large institutions have $1.58B invested in Intra-Cellular Therapies Inc. in 2020 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 71 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 149 → 176 (+27)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
176
Holding in Top 10
2
Calls
$38.2M
Puts
$29.7M
Top Buyers
| 1 | +$84.9M | |
| 2 | +$44.9M | |
| 3 | +$43.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.6M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$23.2M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$16.6M | |
| 3 | -$11.3M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$6.84M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$5.13M |